Transcription Factor ELF1 Modulates Cisplatin Sensitivity in Prostate Cancer by Targeting MEIS Homeobox 2
Chemical Research in Toxicology · 2023
DOI: 10.1021/acs.chemrestox.2c00233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2023. Verfasst von Dengjun Han und 2 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, Zigong Fourth People's Hospital, No.19 Tanmulin Street, Ziliujing District, Zigong City, Sichuan Province 643000, China. Hauptthemen laut MEDLINE: Transcription Factors, Prostatic Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Urology Department, Zigong Fourth People's Hospital, No.19 Tanmulin Street, Ziliujing District, Zigong City, Sichuan Province 643000, China.
ORCID-Profile: Yang Cheng
Zitieren
APA
Han, D., Li, X., & Cheng, Y. (2023). Transcription Factor ELF1 Modulates Cisplatin Sensitivity in Prostate Cancer by Targeting MEIS Homeobox 2. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.2c00233
Vancouver
Han D, Li X, Cheng Y. Transcription Factor ELF1 Modulates Cisplatin Sensitivity in Prostate Cancer by Targeting MEIS Homeobox 2. Chemical Research in Toxicology. 2023. doi:10.1021/acs.chemrestox.2c00233
BibTeX
@article{Han2023,
author = {Han, Dengjun and Li, Xianyong and Cheng, Yang},
title = {Transcription Factor ELF1 Modulates Cisplatin Sensitivity in Prostate Cancer by Targeting MEIS Homeobox 2},
journal = {Chemical Research in Toxicology},
year = {2023},
doi = {10.1021/acs.chemrestox.2c00233}
}
EUVIMED